At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
COSM COSMOS HEALTH INC
Post-Market Trading 05-20 19:31:35 EDT
0.6823
-0.0097
-1.40%
盘后0.6847
+0.0024+0.35%
19:19 EDT
High0.7195Low0.6800Vol27.61K
Open0.7050D1 Closing0.6920Amplitude5.71%
Mkt Cap11.49MTradable Cap10.25MTotal Shares16.85M
T/O19.11KT/O Rate0.18%Tradable Shares15.02M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--
Cosmos Health Participated in Vitafoods Europe 2024; Receives Significant Interest and Numerous New Partnership Inquiries for its Sky Premium Life Nutraceuticals Brand
ACCESSWIRE  ·  05-17
Cosmos Health Participated in Vitafoods Europe 2024; Receives Significant Interest and Numerous New Partnership Inquiries for its Sky Premium Life Nutraceuticals Brand
Medtronic: Looking Ahead To FY 2025 EPS Growth, Shareholder Friendly Actions
seekingalpha  ·  05-14
Medtronic: Looking Ahead To FY 2025 EPS Growth, Shareholder Friendly Actions
Cosmos Health Inc expected to post a loss of 20 cents a share - Earnings Preview
Reuters  ·  05-14
Cosmos Health Inc expected to post a loss of 20 cents a share - Earnings Preview
Lyra Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire  ·  04-30
Lyra Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
BRIEF-Cosmos Health Receives Nasdaq Notice On Late Filing Of Its Form 10-K
Reuters  ·  04-20
BRIEF-Cosmos Health Receives Nasdaq Notice On Late Filing Of Its Form 10-K
Cosmos Health Receives Nasdaq Notice on Late Filing of Its Form 10-K
StreetInsider  ·  04-20
Cosmos Health Receives Nasdaq Notice on Late Filing of Its Form 10-K
HEALWELL Subsidiaries, Khure Health & Pentavere Research Group, to Participate and Present at Upcoming Globally Recognized Medical Conferences
StreetInsider  ·  04-17
HEALWELL Subsidiaries, Khure Health & Pentavere Research Group, to Participate and Present at Upcoming Globally Recognized Medical Conferences
Cosmos Health Inc expected to post a loss of 20 cents a share - Earnings Preview
Reuters  ·  04-10
Cosmos Health Inc expected to post a loss of 20 cents a share - Earnings Preview
Cosmos Health Commences Development of Cloudscreen 2.0, the New Iteration of its Next Generation AI Drug Repurposing Platform
StreetInsider  ·  03-21
Cosmos Health Commences Development of Cloudscreen 2.0, the New Iteration of its Next Generation AI Drug Repurposing Platform
Cosmos Health To Receive Regulatory Approval for C-Scrub Disinfectant in the UK, Obtains Initial Purchase Order; Explores Opportunities Outside EU, Eyeing Global $36Bn+ Market
StreetInsider  ·  03-19
Cosmos Health To Receive Regulatory Approval for C-Scrub Disinfectant in the UK, Obtains Initial Purchase Order; Explores Opportunities Outside EU, Eyeing Global $36Bn+ Market
Cosmos Health secures regulatory approval to sell Sky Premium Life products in UAE
seekingalpha  ·  03-18
Cosmos Health secures regulatory approval to sell Sky Premium Life products in UAE
BRIEF-Cosmos Health Received Regulatory Approval To Sell Its Sky Premium Life Vitamins & Food Supplements In United Arab Emirates Market
Reuters  ·  03-18
BRIEF-Cosmos Health Received Regulatory Approval To Sell Its Sky Premium Life Vitamins & Food Supplements In United Arab Emirates Market
Cosmos Health Receives Regulatory Approval to Sell Sky Premium Life Products in $1.9Bn UAE Nutritional Supplements Market; Secures Initial Purchase Orders
ACCESSWIRE  ·  03-18
Cosmos Health Receives Regulatory Approval to Sell Sky Premium Life Products in $1.9Bn UAE Nutritional Supplements Market; Secures Initial Purchase Orders
Cosmos Health Successfully Completes Acquisition of Pharmatrade’s Assets; Expects to Increase FY 2024 Annual Revenue by over $5 Million
ACCESSWIRE  ·  02-29
Cosmos Health Successfully Completes Acquisition of Pharmatrade’s Assets; Expects to Increase FY 2024 Annual Revenue by over $5 Million
As Trading Frenzies Grip Penny Stocks, Criticism of Nasdaq Grows -- WSJ
Dow Jones  ·  02-23
As Trading Frenzies Grip Penny Stocks, Criticism of Nasdaq Grows -- WSJ
Taglich Brothers Publishes First Coverage Report on Cosmos Health with a Price Target of $4, a Nearly Five-Fold Increase from Current Share Price
ACCESSWIRE  ·  02-22
Taglich Brothers Publishes First Coverage Report on Cosmos Health with a Price Target of $4, a Nearly Five-Fold Increase from Current Share Price
Taglich Brothers Initiates Coverage of Cosmos Health Inc.
GlobeNewswire  ·  02-21
Taglich Brothers Initiates Coverage of Cosmos Health Inc.
Cosmos Health CEO, Greg Siokas, Purchases Shares in the Open Market, Showcasing His Confidence in the Company
ACCESSWIRE  ·  02-20
Cosmos Health CEO, Greg Siokas, Purchases Shares in the Open Market, Showcasing His Confidence in the Company
Taglich Brothers Initiates Coverage of Cosmos Health Inc.
ACCESSWIRE  ·  02-01
Taglich Brothers Initiates Coverage of Cosmos Health Inc.
Cosmos Health files to sell up to 4.87M shares of common stock for holder
seekingalpha  ·  01-30
Cosmos Health files to sell up to 4.87M shares of common stock for holder

Introduction

Company Name.
COSMOS HEALTH INC
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Cosmos Health Inc. provides proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, cosmetics, nursery, health care and baby products, and medical devices. Its nutraceutical product portfolio includes Sky Premium Life and Mediterranation. The company serves wholesale pharmaceutical distributors and independent retail pharmacies. It operates in Greece, Germany, the United Kingdom, Italy, Denmark, Croatia, and Cyprus. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
Issue price:
--